Literature DB >> 17343958

Rationalization of physicochemical characters of oxazolyl thiosemicarbazone analogs towards multi-drug resistant tuberculosis: a QSAR approach.

Revathi A Gupta1, Arun K Gupta, Love K Soni, S G Kaskhedikar.   

Abstract

The emergence of multi-drug resistant (MDR) strains of Mycobacterium tuberculosis and the continuing pandemic of tuberculosis emphasizes the urgent need for the development of new and potent anti-tubercular agents. In an effort to develop new and more effective agents to treat tuberculosis emphasis was focused on quantification of structure-activity relationship of oxazolyl thiosemicarbazone derivatives. The de novo analysis gave insight to some important structural features i.e. nitro group on phenyl ring at R(1) position is optimal for the activity and might be responsible for electronic interaction, while phenyl ring at R position interact with the hydrophobic pocket more effectively as compared to unsubstituted or methyl substituted analogs. Hansch approach offered the understanding and parameterization of interactions of the inhibitor with receptor. Similarly QSAR analysis gave some important physicochemical properties, i.e. empirical aromatic index (ARR) and 3D-MoRSE code value of scattering angle at 8A(-1). These two physicochemical properties shall be helpful in the development of more potent analogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17343958     DOI: 10.1016/j.ejmech.2007.01.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents.

Authors:  Kirk E Hevener; David M Ball; John K Buolamwini; Richard E Lee
Journal:  Bioorg Med Chem       Date:  2008-07-29       Impact factor: 3.641

2.  4-(Diphenyl-amino)-benzaldehyde 4-phenyl-thio-semicarbazone.

Authors:  Rafael Mendoza-Meroño; Laura Menéndez-Taboada; Santiago García-Granda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.